Oncotech's corporate mission is to extend the survival and improve the quality of life of cancer patients. Oncotech provides innovative molecular oncology testing services to over one thousand hospitals throughout the United States and Europe to assist physicians in the care and management of their cancer patients. Oncotech is a market leader in the field of in vitro drug resistance and therapy selection testing, and performs innovative genomic research aimed at rapidly identifying new cancer diagnostics and therapeutics to improve the outcome of cancer patients. Oncotech was acquired by Exiqon A/S in 2008; company ceased operations in 2010.
| Website | https://www.oncotech.org/ |
| Employees | 20 (8 on RocketReach) |
| Founded | 1995 |
| Address | 15501 Red Hill Ave, Tustin, California 92780, US |
| Phone | +1 714-566-0420 |
| Industry | Biotechnology Research |
| Web Rank | 30 Million |
| Keywords | Cancer Diagnostics, Molecular Testing, Molecular Diagnostics, Cancer Treatment, Genomic Testing, Precision Oncology, Clinical Diagnostics, Genetic Testing, Personalized Medicine, Cancer Research, Tumor Profiling, Oncology Biomarkers, Biomarker Discovery, Cancer Biomarkers, Cancer Genetics, Medical Testing, Liquid Biopsy, Healthcare Technology, Pharmaceutical Research |
| Competitors | Genomic Health, Foundation Medicine, Guardant Health, Invitae, Myriad Genetics, carisls, NeoGenomics Laboratories, NantHealth, Roche, bioMérieux +47 more (view full list) |
Looking for a particular Oncotech, Inc. employee's phone or email?
Ami Mehta is the Senior Director New Products and Bus Dev of Oncotech, Inc..
8 people are employed at Oncotech, Inc..
Oncotech, Inc. is based in Tustin, California.